Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 03-1998 | 12-1997 | |
| Sales | 17 | 22 | 24 | 1 | 508 |
| Gross Profit | 10 | 20 | 24 | 1 | 508 |
| Operating Expenses | 1,460 | 1,150 | 0 | 2,210 | 0 |
| Operating Income | -1,443 | -1,128 | 24 | -2,209 | 508 |
| Interest Expense | 30 | 30 | 0 | 40 | 32 |
| Other Income | -7 | -2 | 0 | -11 | -1,986 |
| Pre-tax Income | -1,480 | -1,160 | 24 | -2,260 | -1,511 |
| Net Income Continuous | -1,487 | -1,163 | -852 | -2,260 | -1,511 |
| Net Income | $-1,487 | $-1,163 | $-852 | $-2,260 | $-1,511 |
| EPS Basic Total Ops | -327,832.20 | -262,264.00 | -196,695.80 | N/A | N/A |
| EPS Basic Continuous Ops | -327,832.20 | -262,264.00 | -196,695.80 | N/A | N/A |
| EPS Diluted Total Ops | -327,832.20 | -262,264.00 | -196,695.80 | N/A | N/A |
| EPS Diluted Continuous Ops | -327,832.20 | -262,264.00 | -196,695.80 | N/A | N/A |
| EBITDA(a) | $-1,423 | $-1,108 | $24 | $-2,199 | $508 |